These tumor-intrinsic and APC-intrinsic datasets are directionally consistent—YTHDF1 acts as a brake on anti-tumor immunity—while revealing pathway differences (lysosome–MHC turnover versus STING erosion) that depend on cell type and stimulus (53, 88). This evidence concerns the gene STING1 and neoplasm.